IRX3 Antibodies

Santa Cruz Biotechnology offers a broad range of IRX3 monoclonal antibodies for advanced research in molecular biology. IRX3 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). IRX3, or Iroquois homeobox 3, plays a critical role in regulating gene expression during development and is involved in processes such as neuronal differentiation and metabolic regulation. Research has shown that IRX3 significantly influences obesity and metabolic disorders, making it an important focus of scientific investigation. Understanding IRX3 function can provide insights into developmental biology and potential therapeutic strategies for metabolic diseases. Researchers worldwide are actively studying IRX3's role in cellular pathways and its impact on human health. Current studies are uncovering new connections between IRX3 and various physiological processes. IRX3 research continues to reveal promising directions for therapeutic development. Santa Cruz Biotechnology monoclonal antibodies enable researchers to advance scientific understanding of IRX3 and its role in human health and disease.